Opinion

Swiss Brand Limited, Inc. v. Wenger S.A.

Court
District Court, S.D. Florida
Filed
Dec 2, 2020
Cited by
0 cases
Authority
More cited than 20.1%

applying real and reasonable apprehension of litigation test

How later courts described this case

  • applying real and reasonable apprehension of litigation test
  • “Subsequent cases from the Federal Circuit have recognized that the Court’s opinion in MedImmune constitutes a rejection of the more limited apprehension-of-suit test.”
  • denying motion to dismiss and finding case or controversy existed where defendant “sent correspondence to [plaintiff] suggesting it would sue if its concerns ‘could not be settled on an amicable basis’”
  • “The Supreme Court’s opinion in MedImmune represents a rejection of our reasonable apprehension of suit test.”

Written by the judges who cited it.

The opinion

UNITED STATES DISTRICT COURT FOR THE

SOUTHERN DISTRICT OF FLORIDA

Miami Division

Case Number: 20-21095-CIV-MORENO

SWISS BRAND LIMITED, INC.,

Plaintiff,

vs.

WENGER S.A.,

Defendant.

_________________________________________/

ORDER DENYING MOTION TO DISMISS

THIS CAUSE came before the Court upon Defendant, Wenger S.A.'s “Motion and

Supporting Memorandum to Dismiss[,] No Case or Controversy” (D.E. 6), filed on July 28, 2020.

In this case, the Plaintiff, Swiss Brand Limited, Inc., filed a one-count Complaint for Declaratory

Judgment, seeking a declaration that it has a right to use its marks and that its continued use of its

marks is not likely to cause confusion, mistake or deception. The Defendant, Wenger S.A., now

moves to dismiss, maintaining that Swiss Brand has failed to satisfy the case or controversy

requirement. After careful consideration of all the circumstances, the Court finds that the facts

alleged show that there is “a substantial controversy, between parties having adverse legal

interests, of sufficient immediacy and reality to warrant the issuance of a declaratory judgment.”

See MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118, 127 (2007) (internal citations omitted).

Accordingly, the Court denies Wenger’s motion.

I. BACKGROUND

According to the Complaint for Declaratory Judgment, this case arises from a dispute

between Swiss Brand Limited, Inc., a manufacturer and seller of travel bags and accessories,

clothing, and related items, and Wenger S.A. over Swiss Brand’s right to use its marks. Swiss

Brand alleges that this action also implicates its rights under its federal trademark registrations and

applications seeking the registrations of its marks with the United States Patent and Trademark

Office, which are opposed by Wenger. As to the relief sought, Swiss Brand seeks the following

declarations: (1) confusion, mistake or deception is not likely to result from Swiss Brand’s

continued use of its revised marks; and (2) Swiss Brand is entitled to maintain certain trademark

registrations and to secure registration of the marks depicted below!:

The dispute between the parties began in April 2015 when Wenger filed a Petition for

Cancellation with the Trademark Trial and Appeal Board, seeking cancellation of two of Swiss

Brand’s marks as they were likely to cause confusion with the following Wenger marks:

[Mark 0 «dS Reg. No. & Reg. Date

3,820,133 - July 20, 2010

4.301.579 - March 12, 2013

pS 4.024.369 - September 13,2011 |

©

' Tn its complaint, Swiss Brand specifically requests a declaration that it is entitled to maintain U.S.

Registration Nos. 4,068,183 and 4,369,953 and that it is entitled to secure registration of the marks

shown in U.S. Trademark Ser. Nos. 87/581,407, 87/581,410, 87/581,385, and 87/487,910.

Thereafter, in June and August 2017, Swiss Brand sought to register modified versions of

its cross logo and Original Swiss Brand and Design Mark with the United States Patent and

Trademark Office. This time, in May 2018, Wenger filed a Notice of Opposition with the

Trademark Trial and Appeal Board, claiming that the newly revised marks were also likely to

cause confusion with certain Wenger marks, plus the following additional marks:

Mark U.S. Reg. No. & Reg. Date

3,291,271 - September 11, 2007

3,405,840 - April 1, 2008

Swiss Brand alleges that the parties have been engaged in settlement discussions since

2015, which ultimately prompted Swiss Brand to transition to its revised marks. In October 2018,

Swiss Brand filed a motion with the Trademark Trial and Appeal Board, seeking to amend the

marks in the registrations subject to Wenger’s opposition in 2015. Swiss Brand’s transition to its

revised marks was completed in 2019.

According to the complaint, the parties were on the cusp of a settlement agreement in early

2019. But those hopes were dashed when Wenger’s counsel informed Swiss Brand’s counsel that

Wenger representatives observed certain Swiss Brand products at a trade show, prompting them

to lodge objections to the Swiss Brand marks and forego a possible settlement. As alleged, the

trade show caused Wenger to apparently switch gears, from participating in settlement negotiations

to seemingly collecting evidence of Swiss Brand’s objectionable marks, with “at least one

[Wenger] representative [] approach[ing] Swiss Brand’s display booth and [] photographing the

Swiss Brand product samples, demand[ing] a catalog showing Swiss Brand products, and

express[ing] his objection to Swiss Brand’s use of the [] marks.”

As Swiss Brand alleges, by the end of 2019, the relationship between the parties had

reached a markedly different phase, with Wenger’s counsel reiterating Wenger’s objection to the

Swiss Brand marks and providing photos of the allegedly offending marks to Swiss Brand’s

counsel. Swiss Brand included a copy of the images sent by Wenger’s counsel to Swiss Brand’s

counsel in its complaint, alleging that Wenger objected to Swiss Brand’s use of the following

marks:

SAR

Moreover, in February 2020, Wenger’s counsel notified Swiss Brand’s counsel that

Wenger had filed a complaint for trademark infringement against a third party based upon the use

of the third party’s registered marks, which feature a cross design over a red background. Wenger’s

counsel also provided a copy of that complaint to Swiss Brand’s counsel.

In this action, Swiss Brand brings a one-count declaratory judgment complaint against

Wenger based on its “real and reasonable apprehension that it will be sued for trademark

infringement if it introduces new products bearing the objected-to marks in commercial quantities

into the U.S. market.” Swiss Brand alleges that this real and reasonable apprehension is based on

Wenger’s rejection of a draft settlement agreement, the trade show confrontation, objections to the

Swiss Brand marks communicated through counsel, and Wenger sending a copy of an

infringement action it filed against a third party for the third party’s use of its registered marks,

which allegedly also feature a cross design over a red background. As to Swiss Brand’s fear and

apprehension of introducing new products into the U.S. market, Swiss Brand specifically alleges

that “at least one national retailer—aware of Wenger’s objections—has already expressed its

unwillingness to purchase Swiss Brand’s products absent Wenger’s express consent or a ruling in

Swiss Brand’s favor.”

Wenger now moves to dismiss Swiss Brand’s complaint for declaratory relief, arguing that

the Plaintiff’s single, declaratory judgment claim should be dismissed because the relief sought

amounts to a request for an advisory opinion from this Court. Notably, a day before the Plaintiff’s

response to the motion to dismiss was due, the Defendant filed an 890-page filing purportedly

including email communications between the parties spanning from May 2015 through February

2020. These emails were provided in support of the proposition that no case or controversy exists

between the parties. In its response in opposition, the Plaintiff maintains that it has “establish[ed]

that Defendant’s course of conduct towards Plaintiff has created an ‘actual controversy’ between

the parties under the Supreme Court’s governing MedImmune standard.”

II. LEGAL STANDARD

When ruling on a motion to dismiss, a court must view the complaint in the light most

favorable to the plaintiff and accept the plaintiff's well-pleaded facts as true. See St. Joseph's Hosp.,

Inc. v. Hosp. Corp. of Am., 795 F.2d 948, 953 (11th Cir. 1986). Moreover, “[w]hile legal

conclusions can provide the framework of a complaint, they must be supported by factual

allegations.” Id. at 1950. Those “[f]actual allegations must be enough to raise a right to relief

above the speculative level on the assumption that all of the complaint’s allegations are true.” Bell

Atl. Corp. v. Twombly, 550 U.S. 544, 545 (2007).

III. DISCUSSION

Wenger’s motion to dismiss raises two issues. First, Wenger contends that Swiss Brand

has failed to show that it has a real and reasonable apprehension of litigation. See Windsurfing

Intern. Inc. v. AMF Inc., 828 F.2d 755, 757-758 (Fed. Cir. 1987). Second, Wenger argues that the

allegations in Swiss Brand’s complaint do not amount to a case or controversy, as required under

the Declaratory Judgment Act. 28 U.S.C. § 2201(a).

To the extent that Wenger requests this Court to apply Windsurfing’s two-prong test, this

Court declines to do so in light of the Supreme Court’s decision in MedImmune, Inc. v. Genentech,

Inc., 549 U.S. 118 (2007). As explained below, the Court finds that the MedImmune standard

applies to this case, and, given all the circumstances, the facts alleged in the complaint show the

existence of a case or controversy between the parties to this action.

A. The Supreme Court’s MedImmune standard governs whether there is a case

or controversy in a declaratory judgment action in a trademark case in federal

court.

Under the Declaratory Judgment Act, “[i]n a case of actual controversy within its

jurisdiction . . . any court of the United States . . . may declare the rights and other legal relations

of any interested party seeking such declaration, whether or not further relief is or could be sought.”

28 U.S.C. § 2201(a).

The Supreme Court in MedImmune noted that, in order for a declaratory judgment action

to satisfy the case or controversy requirement, its prior decisions “required that the dispute be

‘definite and concrete, touching the legal relations of parties having adverse legal interests’; and

that it be ‘real and substantial’ and ‘admi[t] of specific relief through a decree of conclusive

character, as distinguished from an opinion advising what the law would be upon a hypothetical

state of facts.’” MedImmune, 549 U.S. at 127 (citing Aetna Life Ins. Co. v. Haworth, 300 U.S. 227,

240-241 (1937)). The Court then reiterated the case or controversy inquiry as follows: “Basically,

the question in each case is whether the facts alleged, under all the circumstances, show that there

is a substantial controversy, between parties having adverse legal interests, of sufficient immediacy

and reality to warrant the issuance of a declaratory judgment.” Id. (quoting Maryland Cas. Co. v.

Pacific Coal & Oil Co., 312 U.S. 270, 273 (1941)).

In its motion to dismiss, Wenger cites Marrero for the proposition that “[w]hether an actual

case or controversy exists in a declaratory judgment action involving trademarks requires a two-

part inquiry”: (1) “the declaratory plaintiff must have a real and reasonable [apprehension] of

litigation”; and (2) “the plaintiff ‘must have engaged in a course of conduct that brought it into

adversarial conflict with the declaratory defendant.’” Marrero Enters. of Palm Beach v. Estefan

Enters., No. 06-81036, 2008 U.S. Dist. LEXIS 33027, at *2-3 (S.D. Fla. Apr. 22, 2008) (internal

citations omitted). As to the first prong of the test, the district court in Marrero cited to the Federal

Circuit’s decision in Windsurfing Intern. Inc. v. AMF Inc., 828 F.2d 755, 757-758 (Fed. Cir. 1987)

(applying real and reasonable apprehension of litigation test), which predates MedImmune.

According to Swiss Brand, since MedImmune, a “more lenient legal standard” now exists

for meeting the Declaratory Judgment Act’s case or controversy requirement. See Sandisk Corp.

v. STMicroelectronics, Inc., 480 F.3d 1372, 1380 (Fed. Cir. 2007) (“The Supreme Court’s opinion

in MedImmune represents a rejection of our reasonable apprehension of suit test.”)2; see also

Micron Tech. v. Mosaid Techs., Inc., 518 F.3d 897, 901 (Fed. Cir. 2008) (“Thus, in place of the

reasonable threat of imminent suit test, the Supreme Court [in MedImmune] required a showing of

whether the facts alleged under all the circumstances show that there is a substantial controversy

2 In Sandisk, the Federal Circuit noted that, in MedImmune, the Supreme Court held that the

Federal Circuit’s prior two-part test’s “reasonable apprehension of suit” requirement conflicted

with prior precedent: Aetna Life Insurance, 300 U.S. 227 (1937) and Maryland Casualty, 312 U.S.

270. Sandisk Corp., 480 F.3d at 1379 (citing MedImmune, 549 U.S. at 132 n. 11).

between the parties having adverse legal interests of sufficient immediacy and reality to warrant

the issuance of a declaratory judgment.”) (internal quotations and citations omitted).

Based on the authorities cited by the parties, the Court finds that the reasonable

apprehension of suit test has been replaced by the more expansive (jurisdiction conferring)

MedImmune standard, which requires a consideration of “all the circumstances” when deciding

whether a controversy exists. See Harris Corp. v. Fed. Express Corp., 670 F. Supp. 2d 1306, 1309

(M.D. Fla. 2009) (“Subsequent cases from the Federal Circuit have recognized that the Court’s

opinion in MedImmune constitutes a rejection of the more limited apprehension-of-suit test.”)

(citing Sandisk Corp., 480 F.3d at 1380). This Court acknowledges that at least one court has

recognized that the viability of the reasonable apprehension of suit test has not been addressed in

the context of a trademark declaratory judgment action, as MedImmune involved a patent

declaratory judgment suit. See Mandala v. Tire Stickers, LLC, No. 6:19-cv-1468, 2020 WL

4743041, at *6 (M.D. Fla. May 27, 2020) (noting that the Eleventh Circuit and other district courts

in the Middle District of Florida have not ruled on this issue). In Mandala, in a report and

recommendation, the court surveyed other courts’ resolution of this issue, noting that “the Second,

Fifth, Ninth, and Tenth Circuits have applied MedImmune in trademark declaratory judgment

actions.” Id. (collecting cases). Ultimately, in Mandala, “[i]n the absence of guidance from the

Eleventh Circuit, [the court] [] follow[ed] the unanimous approach taken by the Court of Appeals

that have examined the issue so far” and applied MedImmune’s standard for determining whether

an actual controversy existed in that trademark declaratory action. Id.

As to district courts in the Southern District of Florida, as noted in Mandala, “[t]here

appears to be some dissonance within the Southern District of Florida,” as some cases appear to

apply the MedImmune standard, while others continue to apply the two-prong test from

Windsurfing. Mandala, 2020 WL 4743041, at *6 n.6. Compare Geltech Sols., Inc. v. Marteal,

Ltd., No. 09-CV-81027, 2010 WL 1791423, at *3 (S.D. Fla. May 5, 2010) (reading MedImmune

as “supplant[ing] the previous ‘apprehension of suit’ test for declaratory judgment jurisdiction”

but noting that “threats of suit and communications between the parties do still play a key role in

determining whether their interests are sufficiently adverse to permit declaratory relief”) with

Gross v. Guzman, No. 11-23028-CIV, 2012 WL 12863969, at *4 (S.D. Fla. July 5, 2012) (applying

Windsurfing’s two-prong test).

To date, it does not appear that the Eleventh Circuit has provided any guidance on the issue,

but it appears that the majority view, as followed in the Second, Fifth, Ninth, and Tenth Circuits,

is that the MedImmune standard governs whether there is a case or controversy under the

Declaratory Judgment Act in a trademark declaratory action. Mandala, 2020 WL 4743041, at *6.

Accordingly, this Court finds that the MedImmune standard applies in this case when

determining, under all the circumstances, whether a case or controversy exists between the parties

in this declaratory judgment, trademark case.

B. Based on the authorities and arguments made here, and, at this stage in the

proceedings, where the Court assumes the allegations in the complaint to be true, a

case or controversy exists between the parties.

Swiss Brand claims that “this is a textbook case for declaratory relief under the

MedImmune standard.” In support of this proposition, Swiss Brand cites HIS IP, Inc. v. Champion

Window, 510 F. Supp. 2d 948, 956 (M.D. Fla. 2007) (denying motion to dismiss and finding case

or controversy existed where defendant “sent correspondence to [plaintiff] suggesting it would sue

if its concerns ‘could not be settled on an amicable basis’”).

In Champion Window, where the district court applied the MedImmune standard, “[the

defendant’s] course of conduct implie[d] the threat of suit” when the defendant sent

correspondence to the plaintiff “suggesting it would sue if its concerns ‘could not be settled on an

amicable basis.’” 510 F. Supp. 2d at 956. There, the district court noted that “[t]he Supreme Court

has recently instructed that in situations where the plaintiff’s actions to avoid imminent injury are

coerced by threatened enforcement of a private party, lower federal courts ‘have long accepted

jurisdiction in such cases.’” Id. (citing MedImmune, 549 U.S. at 130). Notably, the district court

in Champion Window considered the defendant’s opposition in corresponding Trademark Trial

and Appeal Board proceedings in conjunction with the defendant’s letter to the plaintiff. Wenger

did not address Champion Window in its reply.

In its reply, Wenger contends that “[r]eference by [Swiss Brand] to a third party complaint

in the settlement discussions is intentionally and completely misconstrued by [Swiss Brand]” as

“Wenger was showing [Swiss Brand] examples of third party usage different from [Swiss Brand]

usage as a directive of what could and could not be the basis for settlement in further discussions

to resolve issues.” (D.E. 18 ¶ 6). However, Wenger does not cite any support for this proposition

or whether this was discussed or mentioned in its 890-page filing.

At this stage in the proceedings, the Court must accept the plaintiff's well-pleaded facts as

true. See St. Joseph's Hosp., Inc., 795 F.2d at 953. In relevant part, Swiss Brand’s complaint

includes the following factual allegations: “[A]s recently as February 14, 2020, counsel for Wenger

notified counsel for Swiss Brand that Wenger filed a complaint for trademark infringement against

a third party based upon use of the third party’s registered marks, which feature a cross design

over a red background” and that Wenger sent Swiss Brand a copy of the complaint against the

third party. As a result of Wenger’s “rejection of the draft settlement agreement,” “the

confrontation at the trade show,” “the objections subsequently communicated through counsel,”

and the transmittal of the third-party complaint recently filed by Wenger against a third party for

trademark infringement, Swiss Brand has “a real and reasonable apprehension that it will be sued

for trademark infringement if it introduces new products bearing the objected-to marks in

commercial quantities into the U.S. market.” Moreover, Swiss Brand is seeking a declaration that

“confusion, mistake or deception [are] not likely to result from [its] continued use of the Swiss

Brand Marks” and claims that “at least one national retailer—aware of Wenger’s objections—has

already expressed its unwillingness to purchase Swiss Brand’s products absent Wenger’s express

consent or a ruling in Swiss Brand’s favor.”

Thus, based on the facts alleged, under all the circumstances, it appears that there is “a

substantial controversy, between parties having adverse legal interests, of sufficient immediacy

and reality to warrant the issuance of a declaratory judgment.” MedImmune, 549 U.S. at 127. This

case is similar to Champion Window, which Wenger did not address or distinguish in its reply.

Notably, like the defendant in Champion Window, here, Wenger has filed an opposition in

proceedings before the Trademark Trial and Appeal Board. While Swiss Brand does not allege

that Wenger would sue if its concerns “could not be settled on an amicable basis,” under all the

circumstances alleged in the complaint, the Court finds that “[Wenger’s] course of conduct implies

the threat of suit.” Champion Window, 510 F. Supp. 2d at 956. As alleged, Wenger refused to enter

a settlement agreement with Swiss Brand, objected to its marks by correspondence between the

parties’ respective counsel (and at a tradeshow), and opposed Swiss Brand’s applications that are

pending before the Trademark Trial and Appeal Board. The “immediacy and reality” of this

substantial controversy, where the parties have adverse legal interests, is further elucidated by the

allegation that at least one national retailer has expressed its unwillingness to purchase Swiss

Brand’s products until Wenger consents or Swiss Brand obtains a ruling in its favor.

The cases cited by Wenger are distinguishable. In the declaratory judgment action in

Marrero, the district court noted that the plaintiff’s nightclub still used the protected mark, the

name “Coco Bongo,” on Thursday nights. 2008 U.S. Dist. LEXIS 33027, at *4. As a result, the

district court reasoned that the defendant’s amended answer, affirmative defenses, and

counterclaim depended on it proving that it had “a protectable right” as it relates to “Bongo.” Id.

The district court further reasoned that the plaintiff was “under the apprehension of [an] imminent

lawsuit, because [the plaintiff] claim[ed] it continue[d] to use the name ‘Coco Bongos’ on

Thursday nights.” Id. The district court also characterized the defendant’s conditional motion for

voluntary dismissal without prejudice of its amended counterclaim as “quixotic,” as it “read[] more

like a failed settlement proposal rather than a request for judicial relief,” given that its motion for

voluntary dismissal of its counterclaim was conditioned on the Court granting its motion to dismiss

based on lack of subject matter jurisdiction. Id. at *6.

As it relates to Marrero, in its motion to dismiss, Wenger includes a single sentence

discussing that case, stating as follows: “Even though the Court in Marero (sic) found it ‘quixotic’

that a case of a failed settlement proposal was alleged, questions of fact required determination for

further action. Here we do not even have a failed settlement proposal but a continuing settlement

discussion.” As previously noted, in Marrero, the district court characterized the defendant’s

conditional motion for voluntary dismissal without prejudice as “quixotic” and reading more as a

“failed settlement proposal.” Marrero, 2008 U.S. Dist. LEXIS 33027, at *6. No such motion exists

here. While Wenger has not responded to the Swiss Brand’s complaint or filed a counterclaim,

like the plaintiff’s use of the protected mark in Marrero, here, Swiss Brand maintains that it has a

right in its marks, which Wenger has objected to. Additionally, Marrero is also distinguishable

because the district court there applied Windsurfing’s two-prong test, not MedImmune’s standard.

Wenger also cites to Miami Tech, Inc. v. Perez, No. 13-cv-21681, 2013 U.S. Dist. LEXIS

119442, at *4 (S.D. Fla. Aug. 22, 2013) (granting defendant’s motion to dismiss plaintiff’s

declaratory judgment action where the plaintiff “failed to allege that [d]efendant’s [p]atent

infringed upon any patent owned by [the plaintiff]”) and Nationwide Indus. v. D & D Techs. (USA),

Inc., No. 8:12-cv-2372, 2014 U.S. Dist. LEXIS 13068, at *8-9 (M.D. Fla. Jan. 30, 2014) (granting

motion to dismiss and finding no case or controversy existed based, in part, on a cease and desist

letter that did not “expressly threaten litigation” and that did not accuse the plaintiff of any

actionable conduct on the part of the plaintiff, such as a trademark violation). These cases are also

distinguishable.

In Perez, the district granted a motion to dismiss in a declaratory judgment, patent case

because the plaintiff’s complaint failed to seek a declaration that the defendant’s patent was invalid

and, apparently, only sought “redress for [d]efendant’s procedural misconduct before the United

States Patent and Trademark Office.” 2013 U.S. Dist. LEXIS 119442, at *5. Thus, Perez is

distinguishable because, here, Swiss Brand seeks a declaration that its marks are not likely to cause

confusion, mistake or deception.

As to Nationwide Industries, the district court found that “[n]otwithstanding that the parties

are competitors and have been engaged in litigation in the past, [p]laintiff’s apprehension of being

embroiled in yet another lawsuit brought by [d]efendants is simply not sufficiently immediate or

definite to constitute a substantial continuing controversy between the parties warranting

declaratory relief.” 2014 U.S. Dist. LEXIS 13068, at *5. The district court stated that “the cease

and desist letter” there “remain[ed] the primary focus,” as that letter did not “expressly threaten

litigation, did not expressly accuse the plaintiff of “false advertising or violating the Lanham Act”

or include any accusation involving the plaintiff’s “copyright infringement, trademark violation,

or any actionable conduct on the part of [p]laintiffs.” Id. at *8. As a result, the district court

reasoned that “[a]t most, the letter amount[ed] to nothing more than a competitor’s demand for

information regarding [p]laintiff’s products, testing results and warranties” and “[t]he deadline for

responding [in the letter] certainly imposed no actionable obligation on the part of [p]laintiff.” Id.

at *8-9. Moreover, “[t]hat the attorney [for defendants] wrote that he would advise his clients ‘to

take all necessary and appropriate actions’ if [p]laintiff did not respond d[id] not amount to a threat

of litigation.” Id. at *9.

While there is no express threat of litigation by Wenger here, Nationwide Industries is

distinguishable because, based on the facts alleged in the complaint, Swiss Brand states that

Wenger has objected to Swiss Brand’s use of its marks in proceedings before the Trademark Trial

and Appeal Board, Wenger’s counsel advised Swiss Brand’s counsel that Wenger objected to

Swiss Brand’s usage of its marks and “provided [plaintiff’s] counsel for Swiss Brand images

showing the trademark usage to which Wenger object[ed] [to].” Moreover, Swiss Brand alleges

that “counsel for Wenger notified counsel for Swiss Brand that Wenger filed a complaint for

trademark infringement against a third party based upon use of the third party’s registered marks,

which feature a cross design over a red background” (like Swiss Brand’s). Additionally, Swiss

Brand alleges that counsel for Wenger sent it a copy of the third-party complaint.

Accordingly, after considering all the circumstances, the Court finds that, taking the facts

alleged as true, Swiss Brand has alleged a case or controversy as the dispute here is “‘definite and

concrete, touching the legal relations of parties having adverse legal interests’” and it is “‘real and

substantial” and seeks “specific relief through a decree of conclusive character, as distinguished

from an opinion advising that the law would be upon a hypothetical state of facts.” MedImmune,

549 U.S. at 127 (citing Aetna, 300 U.S. at 240-241); see also Vanguard LED Displays, Inc. v.

Daktronics, Inc., No. 8:17-cv-2190-T-30TGW, 2017 WL 10295954, at *2 (M.D. Fla. Nov. 28,

2017) (denying motion to dismiss and finding case or controversy existed where defendant’s

course of conduct implied the immediate threat of suit, namely, defendant’s counsel demanding

that the plaintiff “immediately cease and desist from its infringement of the [] mark[,]” and the

plaintiff sought a “declaration of non-infringement to conclusively establish that it [was] not

infringing in the face of [defendant’s] demands[,]” and the defendant filed an opposition in

proceedings pending before the Trademark Trial and Appeal Board).

IV. CONCLUSION

Accordingly, for the foregoing reasons, it is

ADJUDGED that Wenger’s motion to dismiss is DENIED. Defendant Wenger shall file

its answer and any affirmative defenses to Swiss Brand’s complaint by December 15, 2020. The

Court shall appoint John W. Thornton (jthornton@jamsadr.com) from JAMS as the mediator in

this action by separate order.

DONE AND ORDERED in Chambers at Miami, Florida, this 1st of December 2020.

fare br

FEDERICO A.MORENO]

UNITED STATES DISTRICT JUDGE

Copies furnished to:

Counsel of Record

15

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.